RAPS Euro Convergence 2025

May 13, 2025

Kirsty Watson represented Evidence Prime at RAPS Euro Convergence 2025, held at the Square Brussels Meeting Centre in Brussels from 13 to 16 May. The meeting brought together regulatory professionals working across medical devices, diagnostics and pharmaceuticals, with artificial intelligence and the practical demands of clinical evidence among the programme’s themes.

Literature review within clinical evaluation

For Laser AI, the conference was an opportunity to examine how evidence workflows fit into the wider work of regulatory teams. The programme included a workshop on clinical data and state-of-the-art literature searches for MDR compliance. This is a useful context for evidence synthesis: searching, selecting and assessing literature must produce a body of evidence that other people can examine and understand.

The practical question for teams introducing automation is how to preserve that ability to check the work. Search methods, study-selection decisions and the evidence behind a conclusion need to remain understandable to reviewers. Faster processing is useful when the resulting review can still be evaluated with confidence.

AI validation and professional judgment

The programme also addressed the use of large language models and generative AI in quality management and regulatory work. A preconference workshop considered software validation alongside liability, responsibility and accountability.

RAPS’ report from the meeting captured a related concern: regulators and notified bodies saw potential uses for AI, while emphasising errors and the continuing need for human review. For evidence synthesis, this reinforces the value of evaluating AI within the complete workflow, including how experts detect and resolve mistakes.

Our attendance connected Laser AI’s evidence-synthesis work with the questions regulatory professionals face when assessing the reliability and practical use of AI-assisted processes.

Blank white image with no visible content or details